Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edna Cukierman

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2023
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic CancerAbigail C Cornwell, Arwen A Tisdale, Swati Venkat, et al.
European Urology Oncology|November 24, 2018
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic ResponseAyesha A Shafi, Matthew J Schiewer, Renée de Leeuw, et al.
Cell|July 7, 2011
Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasisJacky G Goetz, Susana Minguet, Inmaculada Navarro-Lérida, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancerKathryn E Maraszek, Arwen A Tisdale, Hunter D Reavis, et al.
Nature Reviews. Disease Primers|May 7, 2026
Pancreatic cancerSusanne Roth, Minoti Apte, Vinod P Balachandran, et al.
Nature Metabolism|July 23, 2020
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumoursZiwen Zhu, Abhinav Achreja, Noah Meurs, et al.
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
Plos One|May 4, 2010
Isoform-specific upregulation of palladin in human and murine pancreas tumorsSilvia M Goicoechea, Brian Bednarski, Christianna Stack, et al.
Nature Communications|March 17, 2022
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanomaClaudia Capparelli, Timothy J Purwin, McKenna Glasheen, et al.
Nature Communications|July 27, 2023
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumorsMatthew Zibelman, Alexander W MacFarlane, Kimberly Costello, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2023
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic CancerAbigail C Cornwell, Arwen A Tisdale, Swati Venkat, et al.
European Urology Oncology|November 24, 2018
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic ResponseAyesha A Shafi, Matthew J Schiewer, Renée de Leeuw, et al.
Cell|July 7, 2011
Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasisJacky G Goetz, Susana Minguet, Inmaculada Navarro-Lérida, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancerKathryn E Maraszek, Arwen A Tisdale, Hunter D Reavis, et al.
Nature Reviews. Disease Primers|May 7, 2026
Pancreatic cancerSusanne Roth, Minoti Apte, Vinod P Balachandran, et al.
Nature Metabolism|July 23, 2020
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumoursZiwen Zhu, Abhinav Achreja, Noah Meurs, et al.
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
Plos One|May 4, 2010
Isoform-specific upregulation of palladin in human and murine pancreas tumorsSilvia M Goicoechea, Brian Bednarski, Christianna Stack, et al.
Nature Communications|March 17, 2022
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanomaClaudia Capparelli, Timothy J Purwin, McKenna Glasheen, et al.
Nature Communications|July 27, 2023
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumorsMatthew Zibelman, Alexander W MacFarlane, Kimberly Costello, et al.
Pageof 10